Table 2 Logistic regression analysis for the risk predictors of SA-AKI.

From: Biomarkers of cell cycle arrest, microcirculation dysfunction, and inflammation in the prediction of SA-AKI

Variables

Univariate logistic

Multivariate logistic1

Multivariate logistic2

OR [95%CI]

P

OR [95%CI]

P

OR [95%CI]

P

Clinical parameters

Age

0.99 [0.96–1.01]

0.290

    

APACHE

1.06 [1.00,1.13]

0.064

    

SOFA

1.22 [1.09,1.37]

0.001**

1.14 [1.01–1.29]

0.032*

1.07 [0.91–1.26]

0.442

Hypertension

1.80 [0.80,4.03]

0.157

    

Diabetes mellitus

1.50 [0.65,3.45]

0.343

    

Vasopressor

2.85 [1.21,6.70]

0.017*

1.15[0.35–3.67]

0.818

0.91 [0.22–3.70]

0.896

Nephrotoxic drugs

1.10 [0.35,3.43]

0.866

    

Diuretics

2.30 [0.96,5.55]

0.063

    

Sepsis shock

2.81 [1.23,6.45]

0.015*

1.45 [0.47–4.40]

0.507

1.12 [0.29–4.30]

0.867

Hospital death

1.64 [0.67,4.01]

0.279

    

Laboratory parameters

Scr

1.00 [0.99,1.02]

0.469

    

WBC

1.04 [0.98,1.09]

0.204

    

Neut

1.04 [0.99,1.11]

0.125

    

NLR

1.01 [1.00,1.02]

0.280

    

CRP

1.01 [1.00,1.02]

0.051

    

PCT

1.04 [1.01,1.07]

0.002**

1.03 [1.00-1.06]

0.039*

1.05 [1.01–1.09]

0.007**

BUN

1.10 [1.04,1.17]

0.001**

1.02 [0.94–1.12]

0.595

0.96 [0.85–1.07]

0.452

SUA

1.01 [1.00,1.01]

0.006**

1.01 [1.00-1.01]

0.006**

1.00 [0.99–1.01]

0.354

PLT

1.00 [1.00,1.00]

0.313

    

Fib

1.19 [0.97,1.46]

0.093

    

D-D

1.32 [1.04,1.68]

0.024*

1.14 [0.89–1.52]

0.334

1.19 [0.85–1.75]

0.342

FDP

1.01 [0.99,1.03]

0.200

    

Novel biomarkers

TIMP-2

1.04 [1.02,1.06]

0.000**

    

IGFBP-7

1.15 [1.07,1.24]

0.000**

    

TIMP-2×IGFBP-7

3.30 [1.91,5.70]

0.000**

  

2.71 [1.52–4.84]

0.001**

Ang-2

1.21 [1.10,1.33]

0.000**

  

1.19 [1.06–1.33]

0.004**

  1. APACHE  acute physiology and chronic health evaluation, SOFA  sequential organ failure assessment, Scr  serum creatinine, WBC  white blood cell count, Neut  neutrophils count, NLR  neutrophil-to-lymphocyte ratio, PLT  platelet, CRP  C-reactive protein, PCT  procalcitonin, BUN  urea, SUA  serum uric acid, Fib fibrinogen, D-D  D-dimer, FDP  Fibrin degradation products, TIMP-2  tissue inhibitor of metalloproteinase-2, IGFBP-7  insulin-like growth factor-binding protein 7, Ang-2  angiopoietin-2, OR  odds ratio, *P < 0.05, **P < 0.01.